Banner

Coenzyme Q10 supplementation mitigates piroxicam-induced oxidative injury and apoptotic pathways in the stomach, liver, and kidney

• 2020
Back
Publication Information
Authors Ahmed Abdeen a,b,*, Afaf Abdelkader b,c, Dina Elgazzar d, Mohamed Aboubakr e, Omnia A. Abdulah f, Khaled Shoghy g, Mohamed Abdel-Daim h,i, Hamed A. El-Serehy h, Agnieszka Najda j, Amany El-Mleeh k
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type International
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Piroxicam (PM) is an oxicam-NSAID commonly recommended for various pain and associated inflammatory
disorders. However, it is reported to have a gastric and hepato-renal toxic effect. Therefore, the current research
was planned to investigate the possible mechanisms behind the mitigating action of the coenzyme (CoQ10), a
natural, free radical scavenger, against PM tissue injury. Rats were assigned to five equal groups; Control, CoQ10
(10 mg/kg, orally), PM (7 mg/kg, i.p.), CoQ + PM L, and CoQ + PM H group. After 28 days, PM provoked severe
gastric ulceration and marked liver and kidney damage indicated by an elevated gastric ulcer index and
considerable alteration in liver and kidney biochemical tests. The toxic effects might be attributed to mitochondrial
dysfunction and excess generation of reactive oxygen species (ROS), as indicated by enhanced
malondialdehyde (MDA) levels along with decreased reduced-glutathione (GSH) levels and catalase (CAT) activity.
Apoptotic cell death also was demonstrated by increased regulation of activated caspase-3 in the stomach,
liver, and kidney tissues. Interestingly, external supplementation of CoQ10 attenuated the PM-inflicted deleterious
oxidative harm and apoptosis. This ameliorative action was ascribed to the free radical scavenging activity
of CoQ10.